← FDA Drug Approvals (Drugs@FDA)
LOPINAVIR AND RITONAVIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2025-12-11
Drug application
- FDA Application #
ANDA214696- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LOPINAVIR AND RITONAVIR
- Generic name
- Lopinavir
- Active ingredients
- LOPINAVIR; RITONAVIR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MICRO LABS
- First approval
- 2025-12-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown